Marieke Brugmans1, Aurélie Serrero1, Martijn Cox1, Oleg Svanidze2, Frederick J Schoen3. 1. Xeltis BV, De Lismortel 31, 5612AR, Eindhoven, The Netherlands. 2. Xeltis AG, Muhlebachstrasse 28, Zurich, Switzerland. 3. Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA. Electronic address: fschoen@bwh.harvard.edu.
Abstract
BACKGROUND: Right ventricular outflow tract (RVOT) conduits used in children with congenital heart disease often degenerate rapidly or develop other complications, and they do not grow with the patient. This leads to multiple surgeries until adult-sized conduits can be implanted. We report experimental in vivo experience with an entirely synthetic absorbable graft, designed to be replaced by tissue in-vivo by host cells, in a process termed Endogenous Tissue Restoration (ETR), and to grow commensurate with somatic growth. METHODS: We characterized the structure, mechanical properties, biocompatibility, and in vivo remodelling of a bioabsorbable polyester based on the self-complementary ureido-pyrimidinone (UPy) quadruple hydrogen-bonding motif. Electrospinning was used to process the polymer into a tubular graft with a highly porous wall structure, which was implanted as a pulmonary artery interposition graft in 9 adult sheep with a maximum follow-up of 1 year, followed by pathologic and mechanical analysis. RESULTS: All grafts were patent by transthoracic echocardiography. Eight were intact at post-mortem examination. One graft had aneurysmal dilation. Graft polymer resorption in vivo was consistent among specimens. Histologic examination revealed progressive tissue replacement of graft polymer, ongoing at one year, with remodeling to a structure that had some key features of native vascular wall. Burst pressures for all explants at 8 weeks and beyond were higher than those of native pulmonary artery (PA) and largely determined by newly formed tissue. CONCLUSIONS: Preclinical studies of a new, absorbable polymeric graft for PA replacement showed remodelling by endogenous cells up to one-year follow-up. Our results show that ETR leads to progressive and substantial replacement of an off-the-shelf synthetic bioabsorbable conduit by functional host tissue to one year in sheep. Thus, further development of this novel concept is warranted.
BACKGROUND: Right ventricular outflow tract (RVOT) conduits used in children with congenital heart disease often degenerate rapidly or develop other complications, and they do not grow with the patient. This leads to multiple surgeries until adult-sized conduits can be implanted. We report experimental in vivo experience with an entirely synthetic absorbable graft, designed to be replaced by tissue in-vivo by host cells, in a process termed Endogenous Tissue Restoration (ETR), and to grow commensurate with somatic growth. METHODS: We characterized the structure, mechanical properties, biocompatibility, and in vivo remodelling of a bioabsorbable polyester based on the self-complementary ureido-pyrimidinone (UPy) quadruple hydrogen-bonding motif. Electrospinning was used to process the polymer into a tubular graft with a highly porous wall structure, which was implanted as a pulmonary artery interposition graft in 9 adult sheep with a maximum follow-up of 1 year, followed by pathologic and mechanical analysis. RESULTS: All grafts were patent by transthoracic echocardiography. Eight were intact at post-mortem examination. One graft had aneurysmal dilation. Graft polymer resorption in vivo was consistent among specimens. Histologic examination revealed progressive tissue replacement of graft polymer, ongoing at one year, with remodeling to a structure that had some key features of native vascular wall. Burst pressures for all explants at 8 weeks and beyond were higher than those of native pulmonary artery (PA) and largely determined by newly formed tissue. CONCLUSIONS: Preclinical studies of a new, absorbable polymeric graft for PA replacement showed remodelling by endogenous cells up to one-year follow-up. Our results show that ETR leads to progressive and substantial replacement of an off-the-shelf synthetic bioabsorbable conduit by functional host tissue to one year in sheep. Thus, further development of this novel concept is warranted.
Authors: Kevin M Blum; Jacob C Zbinden; Abhay B Ramachandra; Stephanie E Lindsey; Jason M Szafron; Aaron J Trask; Jay D Humphrey; Alison L Marsden; Toshiharu Shinoka; Christopher K Breuer; James W Reinhardt; Megan Heitkemper; Cameron A Best; Gabriel J M Mirhaidari; Yu-Chun Chang; Anudari Ulziibayar; John Kelly; Kejal V Shah; Joseph D Drews; Jason Zakko; Shinka Miyamoto; Yuichi Matsuzaki; Ryuma Iwaki; Hira Ahmad; Robbie Daulton; Drew Musgrave; Matthew G Wiet; Eric Heuer; Emily Lawson; Erica Schwarz; Michael R McDermott; Rajesh Krishnamurthy; Ramkumar Krishnamurthy; Kan Hor; Aimee K Armstrong; Brian A Boe; Darren P Berman Journal: Commun Med (Lond) Date: 2022-01-10
Authors: Julia Marzi; Emma C Munnig Schmidt; Eva M Brauchle; Tamar B Wissing; Hannah Bauer; Aurelie Serrero; Serge H M Söntjens; Anton W Bosman; Martijn A J Cox; Anthal I P M Smits; Katja Schenke-Layland Journal: Front Cardiovasc Med Date: 2022-05-17
Authors: Joseph D Drews; Victoria K Pepper; Cameron A Best; Jason M Szafron; John P Cheatham; Andrew R Yates; Kan N Hor; Jacob C Zbinden; Yu-Chun Chang; Gabriel J M Mirhaidari; Abhay B Ramachandra; Shinka Miyamoto; Kevin M Blum; Ekene A Onwuka; Jason Zakko; John Kelly; Sharon L Cheatham; Nakesha King; James W Reinhardt; Tadahisa Sugiura; Hideki Miyachi; Yuichi Matsuzaki; Julie Breuer; Eric D Heuer; T Aaron West; Toshihiro Shoji; Darren Berman; Brian A Boe; Jeremy Asnes; Mark Galantowicz; Goki Matsumura; Narutoshi Hibino; Alison L Marsden; Jordan S Pober; Jay D Humphrey; Toshiharu Shinoka; Christopher K Breuer Journal: Sci Transl Med Date: 2020-04-01 Impact factor: 17.956
Authors: Madeline Cramer; Jordan Chang; Hongshuai Li; Aurelie Serrero; Mohammed El-Kurdi; Martijn Cox; Frederick J Schoen; Stephen F Badylak Journal: J Biomed Mater Res A Date: 2021-07-29 Impact factor: 4.854